Florida Cancer Specialists & Research Institute, LLC (FCS) today reported key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM).
Florida Cancer Specialists & Research Institute (FCS) today held a ribbon-cutting ceremony to mark the opening of its new state-of-the-art cancer center in Manatee County.
Jessica Stine, MD, gynecologic oncologist with Florida Cancer Specialists & Research Institute (FCS), and an advanced robotic surgeon who performs the highest volume of GYN robotic surgery in the Tampa Bay area, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.
Florida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art Trinity Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders.
Tampa General Hospital (TGH), the Florida Cancer Specialists & Research Institute (FCS), Proton Therapy Partners and Florida Urology Partners today announced a new collaborative partnership with plans to build a proton therapy center in Tampa Bay that would offer patients across the West Coast of Florida access to an advanced alternative to conventional radiation treatment for cancer and within the convenience of their own backyard.
FCS received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
Florida Cancer Specialists & Research Institute Ranked Among Top Performing Oncology Practices in the Country for Quality & Cost Saving MeasuresFlorida Cancer Specialists & Research Institute, LLC (FCS) today reported key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM).
Florida Cancer Specialists & Research Institute Announces Senior Leadership Promotions & AppointmentsFlorida Cancer Specialists & Research Institute (FCS) is pleased to announce the following promotions and additions to its senior leadership team.
Florida Cancer Specialists & Research Institute Celebrates Opening of New State-of-the-Art Cancer Center in BradentonFlorida Cancer Specialists & Research Institute (FCS) today held a ribbon-cutting ceremony to mark the opening of its new state-of-the-art cancer center in Manatee County.
Florida Cancer Specialists & Research Institute Gynecologic Oncologist Jessica Stine, MD Named National Gynecologic Oncology Observation SiteJessica Stine, MD, gynecologic oncologist with Florida Cancer Specialists & Research Institute (FCS), and an advanced robotic surgeon who performs the highest volume of GYN robotic surgery in the Tampa Bay area, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.
Florida Cancer Specialists & Research Institute Expands Services in Pasco CountyFlorida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art Trinity Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders.
Tampa General Hospital, Florida Cancer Specialists, Proton Therapy Partners and Florida Urology Partners Come Together with Plans to Open the Region’s First Proton Therapy CenterTampa General Hospital (TGH), the Florida Cancer Specialists & Research Institute (FCS), Proton Therapy Partners and Florida Urology Partners today announced a new collaborative partnership with plans to build a proton therapy center in Tampa Bay that would offer patients across the West Coast of Florida access to an advanced alternative to conventional radiation treatment for cancer and within the convenience of their own backyard.
Florida Cancer Specialists & Research Institute Breast Cancer Partnership Receives National AccreditationFCS received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
FCS Physicians Co-Author Integrated Safety Analysis of Umbralisib in Lymphoid MalignanciesThree medical oncologists at FCS are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.